Epirium Bio Announces FDA Clearance of Investigational New Drug Application for MF-300 and Appointment of Alex Casdin as New Chief Executive Officer and Russell Cox as Executive Chairman by Carolyn Helms | Dec 23, 2024 | Portfolio News
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions by Carolyn Helms | Dec 18, 2024 | Portfolio News
Veradermics Raises $75 Million in Series B Financing and Initiates Phase 2/3 Trial for Hair Loss by Carolyn Helms | Dec 11, 2024 | Portfolio News
Opna Bio Announces Interim Data from Phase 1 Combination Study of OPN-2853 with Ruxolitinib in Patients with Advanced Myelofibrosis by Carolyn Helms | Dec 9, 2024 | Portfolio News
WelbeHealth Expands PACE Access to Vulnerable Seniors with Opening of Carson Center by Carolyn Helms | Dec 3, 2024 | Portfolio News
